Source: Clinical Ophthalmology. Unidade: FMRP
Subjects: CÉLULAS-TRONCO, DEGENERAÇÃO MACULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COTRIM, Carina Costa et al. Intravitreal use of bone marrow mononuclear fraction containing CD34+ stem cells in patients with atrophic age-related macular degeneration. Clinical Ophthalmology, v. 11, p. 931-938, 2017Tradução . . Disponível em: https://doi.org/10.2147/opth.s133502. Acesso em: 14 fev. 2026.APA
Cotrim, C. C., Toscano, L., Messias, A. M. V., Jorge, R., & Siqueira, R. C. (2017). Intravitreal use of bone marrow mononuclear fraction containing CD34+ stem cells in patients with atrophic age-related macular degeneration. Clinical Ophthalmology, 11, 931-938. doi:10.2147/opth.s133502NLM
Cotrim CC, Toscano L, Messias AMV, Jorge R, Siqueira RC. Intravitreal use of bone marrow mononuclear fraction containing CD34+ stem cells in patients with atrophic age-related macular degeneration [Internet]. Clinical Ophthalmology. 2017 ; 11 931-938.[citado 2026 fev. 14 ] Available from: https://doi.org/10.2147/opth.s133502Vancouver
Cotrim CC, Toscano L, Messias AMV, Jorge R, Siqueira RC. Intravitreal use of bone marrow mononuclear fraction containing CD34+ stem cells in patients with atrophic age-related macular degeneration [Internet]. Clinical Ophthalmology. 2017 ; 11 931-938.[citado 2026 fev. 14 ] Available from: https://doi.org/10.2147/opth.s133502
